Expert Review Of Clinical Immunology

Expert Review Of Clinical Immunology英文簡介

Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology.

Articles focus on the following key areas:

? Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines

? Performance and benefits of newly approved therapeutic agents

? New diagnostic approaches

? Screening and patient stratification

? Pharmacoeconomic studies

? New therapeutic indications for existing therapies

? Adverse effects, occurrence and reduction

? Prospects for medicines in late-stage trials approaching regulatory approval

? Novel treatment strategies

? Epidemiological studies

? Commentary and comparison of treatment guidelines

Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases.

Expert Review Of Clinical Immunology中文簡介

《Expert Review Of Clinical Immunology》是一本由TAYLOR & FRANCIS LTD出版商出版的專業(yè)醫(yī)學期刊，該刊創(chuàng)刊于2005年，刊期Bimonthly，該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學科：醫(yī)學 3區(qū)，小類學科：免疫學 3區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q2。該刊發(fā)文范圍涵蓋免疫學等領(lǐng)域，旨在及時、準確、全面地報道國內(nèi)外免疫學工作者在該領(lǐng)域取得的最新研究成果、工作進展及學術(shù)動態(tài)、技術(shù)革新等，促進學術(shù)交流，鼓勵學術(shù)創(chuàng)新。2021年影響因子為5.124，平均審稿速度較慢,6-12周。

中科院分區(qū)最新升級版（當前數(shù)據(jù)版本：2021年12月最新升級版）

大類學科	分區(qū)	小類學科	分區(qū)	Top期刊	綜述期刊
醫(yī)學	3區(qū)	IMMUNOLOGY 免疫學	3區(qū)	否	是

JCR分區(qū)（當前數(shù)據(jù)版本：2021-2022年最新版）

JCR分區(qū)等級	JCR所屬學科	分區(qū)	影響因子
Q2	IMMUNOLOGY	Q2	5.124

期刊指數(shù)

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
5.124	42	7.17%	27.88%	未開放	較慢,6-12周

IF值(影響因子)趨勢圖